Clinical Trial Update: Metabolic Impact of Intermittent Fasting in Early Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating the metabolic impact of intermittent fasting in individuals with early type 2 diabetes mellitus and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Diabetes Mellitus, Type 2, Obesity | NA | Status: COMPLETED